WallStSmart
XLO

Xilio Development Inc

NASDAQ: XLO · HEALTHCARE · BIOTECHNOLOGY

$7.92
+1.67% today

Updated 2026-04-30

Market cap
$45.80M
P/E ratio
P/S ratio
1.05x
EPS (TTM)
$-4.19
Dividend yield
52W range
$6 – $17
Volume
0.2M

Xilio Development Inc (XLO) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-10.9%
Last 4 quarters
Revenue YoY growth
+693.9%
Most recent quarter
EPS YoY growth
+503.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-3.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-8.5%
2025-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-04$0.81+907.7%$0.53$0.54+2.6%
2025-11-13$-0.11-120.0%$0.77$0.71-8.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.10$0.81+907.7%$13.69M+693.9%
2025-09-30$-0.05$-0.11-120.0%$19.07M+742.5%
2025-06-30$-0.10$-0.16-60.0%$8.08M+243.0%
2025-03-31$-0.11$-0.18-63.6%$2.93M+1.0%
2024-12-31$-0.26$-0.20+22.1%$1.72M
2024-09-30$-0.25$-0.22+12.0%$2.26M
2024-06-30$-0.23$-0.24-4.3%$2.36M
2024-03-31$-0.11$-0.62-463.6%$2.90M
2023-12-31$-0.64$-0.64+0.0%
2023-09-30$-0.81$-0.61+24.7%
2023-06-30$-0.87$-0.70+19.5%
2023-03-31$-0.89$-0.83+6.7%
2022-12-31$-0.78$-0.82-5.1%

Frequently asked questions

Has Xilio Development Inc beaten earnings estimates?
Xilio Development Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -10.9% over the last 4 quarters.
How does XLO stock react to earnings?
XLO stock has moved an average of -3.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Xilio Development Inc's revenue growth rate?
Xilio Development Inc reported year-over-year revenue growth of +693.9% in its most recent quarter, with EPS growing +503.9% year-over-year.